Transcription of ICH HARMONISED TRIPARTITE GUIDELINE
{{id}} {{{paragraph}}}
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE pharmaceutical QUALITY SYSTEM Q10 Current Step 4 version dated 4 June 2008 This GUIDELINE has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. pharmaceutical Quality System Q10 Document History Code History Date Q10 Approval by the Steering Committee under Step 2 and release for public consultation.
international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline pharmaceutical …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
PHARMACEUTICAL DEVELOPMENT FOR, Pharmaceutical development for multisource (generic) pharmaceutical, Pharmaceutical Development, DEVELOPMENT OF PAEDIATRIC MEDICINES:, Development of paediatric medicines: points to consider in pharmaceutical development, Product Lifecycle Management for the, Development, Pharmaceutical, Oracle Pharmaceutical, Product Lifecycle Management for the Pharmaceutical, Stability Testing of Pharmaceutical, Stability testing of pharmaceutical products